Behavioral Research of Environment and Air Pollution Through Education

Overview

The BREATHE (Behavioral Research of Environment and Air Pollution Through Education) study is a pilot randomized control trial comparing the efficacy of a classroom-based intervention to no intervention in helping middle-school students understand and make behavioral decisions about air pollution. This study is designed to evaluate the effectiveness of the classroom-based intervention on knowledge of air pollution, understanding of air pollution sources, and behavioral choices made to reduce both contributions to air pollution and personal exposure to air pollution.

It has been well established that pollution is a racial and economic issue. Low-income areas with populations of predominantly people of color tend to be those with the highest rates of pollution and the largest particulate exposure. Creation of and exposure to this pollution is a key issue for the health of inhabitants of these areas, and of those in the broader surrounding areas. By developing, and assessing the effectiveness of, the investigators hope that the BREATHE study will give the investigators insights into how to better combat this higher exposure and reduce the health risks for those in high pollution areas.

The study will take place in 4 visits over a period of 12 months. The hypothesis is that the classroom-based intervention will be effective in leading to behaviors that will reduce exposure to air pollution.

Full Title of Study: “Behavioral Research of Environment and Air Pollution Through Education (BREATHE Study)”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Prevention
    • Masking: Single (Participant)
  • Study Primary Completion Date: December 2020

Interventions

  • Behavioral: Air Pollution Education
    • Students are presented with a one-hour interactive session on air pollution.
  • Other: Non-Air Pollution Education
    • Students are presented with a one-hour interactive session on vaccines.

Arms, Groups and Cohorts

  • Experimental: Air Pollution Education
    • Students are presented with a one-hour interactive information session about air pollution and the environment.
  • Placebo Comparator: Non-Air Pollution Education
    • Students are presented with a one-hour interactive information session about vaccines.

Clinical Trial Outcome Measures

Primary Measures

  • Behavior Change Assessed by Questionnaires
    • Time Frame: Assessed immediately after intervention, and at 3 months, 6 months, and 12 months
    • Change in Future Behavior as it Relates to Personal Choices and Support for Policies and Regulations

Secondary Measures

  • Improvement in Understanding Assessed by Questionnaires
    • Time Frame: Assessed immediately after intervention, and at 3 months, 6 months, and 12 months
    • Improvement in Understanding of Air Pollution and Its Public Health Ramification

Participating in This Clinical Trial

Inclusion Criteria

  • Ability to read, write, and understand English at a middle school level
  • Willing to participate in follow up visits

Exclusion Criteria

  • Learning disabilities such as autism
  • Moving out of the area in the next 6 months
  • Inability to complete the questionnaires

Gender Eligibility: All

Minimum Age: 13 Years

Maximum Age: 15 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • University of California, San Francisco
  • Provider of Information About this Clinical Study
    • Principal Investigator: Mehrdad Arjomandi, Professor of Medicine in the Division of Pulmonary, Critical Care, Allergy, Immunology, and Sleep Medicine – University of California, San Francisco

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.